Clinical Trial Update: Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating transfer of bone marrow-derived stem cells for spinal cord injury has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• bone marrow-derived stem cell therapy (bone marrow-derived stem cells)

Snippet

Sponsor: TCA Cellular Therapy | Conditions: Spinal Cord Injury | Phase 1 | Status: SUSPENDED